This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

Global Hemoglobin A1c Monitoring Industry

Graph/Chart) II-30

Therapeutic Options for Diabetes II-31

Oral Medication for Type 2 Diabetes II-31

Side Effects of Insulin Therapy II-32

Side Effects II-32

Maintaining A1c Test Result Below 7% II-32

Common Diabetes Management Practices II-32

4. PRODUCT APPROVALS/INTRODUCTIONS II-33

EKF Obtains CE Mark for Quo-Lab POC HbA1c Analyser II-33

Streck Launches A1c-Cellular Linearity Verification Material II-33

Abbott Obtains CE Marking for ARCHITECT HbA1c (IA) Fully

Automated Assay II-34

Trinity Obtains FDA Approval for Premier Hb9210 HbA1c Device II-34

Siemens Launches Fortified Version of DCA Vantage Analyzer II-35

Tosoh Launches New Assay on its AIA-600II and AIA-360 Analyzers II-35

Siemens Unveils ADVIA® Chemistry HbA1c Assay II-36

Bayer Healthcare Introduces A1CNow® SELFCHECK II-36

Randox Introduces HbA1c Test II-36

Animas Obtains FDA Approval for OneTouch Glucose Management

System II-36

ARKRAY USA Obtains FDA Approval for GLUCOCARD II-37

Bayer's Breeze Blood Glucose Monitoring System Receives

Commendation II-37

Quantimetrix Develops GlycoHemosure II-37

Olympus Life Science Europa Unveils HbA1c assay II-38

Siemens Healthcare Introduces DCA Vantage™ Analyser II-38

5. RECENT INDUSTRY ACTIVITY II-39

Trinity Inks Distribution Agreement with Menarini for Premier

Hb9210 II-39

Danaher Acquires Beckman Coulter II-39

Geonostics Takes Over Consumer Diabetes Tests of FlexSite II-39

EKF Diagnostics Takes Over Quotient Diagnostics II-39

ADA Recommends HbA1c Lab Test for Identification of Pre-Diabetes II-40

HemoCue and MEC Dynamics Inks Distribution Agreement for Avie

A1c POC Test II-40

Trinity Biotech Submits TRIstat™ CLIA Application to FDA II-40

Arkray Partners with Elitech to Supply In-vitro Diagnostic

Systems II-41

Quest Diagnostics Receives Accreditation from NABL and CAP II-41

Quest Diagnostics Achieves Accreditation for its Laboratory in

India II-41

PPD Inks an Agreement with PUL to Expand Lab Services into China II-42

Roche Inks Marketing Agreement with Mankind Pharma II-42

Nicholas Piramal Forms Joint Venture with Arkray II-42

Quotient Diagnostics to Commence Production of Quo-Test System II-42

Pelikan and Eli Lilly Sign Co-Promotion Agreement II-43

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 +2.54 0.14%
NASDAQ 4,095.5160 +9.2910 0.23%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs